from Reuters: Company News https://reut.rs/2DOMaeX
REFILE-UPDATE 1-FDA approves cheaper Botox rival to treat frown lines
An injection to treat forehead wrinkles is set to rival Allergan's Botox after U.S. regulators approved Evolus Inc's cheaper treatment on Friday, sending its shares up about 5 percent after the bell.
from Reuters: Company News https://reut.rs/2DOMaeX
from Reuters: Company News https://reut.rs/2DOMaeX
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment